SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-004514
Filing Date
2021-02-05
Accepted
2021-02-05 16:30:25
Documents
12
Period of Report
2021-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20210203.htm   iXBRL 8-K 42007
  Complete submission text file 0001564590-21-004514.txt   178872

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210203.xsd EX-101.SCH 5768
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210203_lab.xml EX-101.LAB 20981
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210203_pre.xml EX-101.PRE 12535
5 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20210203_htm.xml XML 3794
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 21596001
SIC: 2834 Pharmaceutical Preparations